Baird Financial Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $253K | Hold |
|
|||||
|
2025
Q2 | $214K | Hold |
|
|||||
|
2025
Q1 | $231K | Hold |
|
|||||
|
2024
Q4 | $227K | Hold |
|
|||||
|
2024
Q3 | $234K | Hold |
|
|||||
|
2024
Q2 | $210K | Sell |
|
|||||
|
2024
Q1 | $241K | Hold |
|
|||||
|
2023
Q4 | $232K | Sell |
|
|||||
|
2023
Q3 | $230K | Hold |
|
|||||
|
2023
Q2 | $237K | Sell |
|
|||||
|
2023
Q1 | $929K | Buy |
|
|||||
|
2022
Q4 | $246K | Hold |
|
|||||
|
2022
Q3 | $241K | Hold |
|
|||||
|
2022
Q2 | $252K | Hold |
|
|||||
|
2022
Q1 | $272K | Hold |
|
|||||
|
2021
Q4 | $277K | Hold |
|
|||||
|
2021
Q3 | $285K | Hold |
|
|||||
|
2021
Q2 | $311K | Hold |
|
|||||
|
2021
Q1 | $302K | Sell |
|
|||||
|
2020
Q4 | $316K | Hold |
|
|||||
|
2020
Q3 | $264K | Sell |
|
|||||
|
2020
Q2 | $302K | Hold |
|
|||||
|
2020
Q1 | $253K | Buy |
|
|||||
|
2019
Q4 | $318K | Hold |
|
|||||
|
2019
Q3 | $248K | Sell |
|
|||||
|
2019
Q2 | $920K | Sell |
|
|||||
|
2019
Q1 | $961K | Sell |
|
|||||
|
2018
Q4 | $3.83M | Sell |
|
|||||
|
2018
Q3 | $7.34M | Buy |
|
|||||
|
2018
Q2 | $5.61M | Buy |
|
|||||
|
2018
Q1 | $5.44M | Buy |
|
|||||
|
2017
Q4 | $5.59M | Sell |
|
|||||
|
2017
Q3 | $5.48M | Sell |
|
|||||
|
2017
Q2 | $5.69M | Buy |
|
|||||
|
2017
Q1 | $5.5M | Buy |
|
|||||
|
2016
Q4 | $4.21M | Buy |
|
|||||
|
2016
Q3 | $4.58M | Sell |
|
|||||
|
2016
Q2 | $5.17M | Buy |
|
|||||
|
2016
Q1 | $4.91M | Buy |
|
|||||
|
2015
Q4 | $6.19M | Buy |
|
|||||
|
2015
Q3 | $5.67M | Sell |
|
|||||
|
2015
Q2 | $7.58M | Buy |
|